Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-06

Clinical Trial Update: Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating intravenous IDOV-SAFETM in patients with advanced solid tumors and is currently recruiting to assess safety and prelimina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IDOV-SAFETM

Snippet

Sponsor: Fudan University | Conditions: Advanced Malignant Solid Tumor | EARLY_Phase 1 | Status: RECRUITING